View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Orion Corporation
17 February 2015

Orion Pharma Animal Health and Vetoquinol Enter Distribution Collaboration from 1 January 2015

Orion Pharma Animal Health and Vetoquinol have announced their collaboration regarding the distribution of Orion’s sedatives product family alpha-2 agonists and antagonist Dexdomitor, Domitor and Domosedan and Antisedan.

Vétoquinol will be the distributor in selected European countries for Orion sedative products. The collaboration is effective from 1 January 2015.

Vetoquinol is responsible for marketing the sedatives to customers in the UK, Germany, France, Ireland, the Netherlands, Belgium, Luxembourg and Italy.

Orion Pharma Animal Health vice-president Niclas Lindstedt said: "Orion Pharma Animal Health foresees that this new alliance with a dedicated and recognised partner will further strengthen the position with customers of the well-accepted Orion sedatives range."

Vetoquinol CEO Matthieu Frechin said: "The inclusion of the sedative products from Orion Pharma Animal Health in our pain and surgery product range will further reinforce our offer to our customers; it is a an additional proof of our willingness to be a partner of choice for all vet surgeons in the field of pain and anaesthesia."

Orion has three modern pharmaceutical plants all located in Finland. We manufacture tablets, capsules, small volume parenterals, dry powder inhalers, creams, gels, ointments, liquids and...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology